Sponsored by:

Nuclear Medicine: Page 222

Mirada inks deal with clinical trial firm
By AuntMinnie.com staff writers
Medical imaging software developer Mirada Medical has signed an agreement with clinical trial support firm ABX-CRO that will allow the company to use Mirada's multimodality imaging applications for clinical trials in oncology and the neurosciences.
September 14, 2011
GE to invest $1B in new oncology R&D
By AuntMinnie.com staff writers
GE Healthcare has announced plans to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging offerings, as well as technologies for manufacturing biopharmaceuticals and for cancer research.
September 14, 2011
BCBS Delaware hit with preauthorization fine
By AuntMinnie.com staff writers
Delaware Insurance Commissioner Karen Weldin Stewart has fined Blue Cross/Blue Shield of Delaware (BCBSD) $325,000 in connection with deficiencies in BCBSD's nuclear cardiac imaging testing preauthorization process, Stewart's office announced.
September 14, 2011
ASCO: PET/CT helps predict metastatic breast cancer outcome
By Kate Madden Yee
Maximum standardized uptake values on PET/CT scans can help predict prognosis in breast cancer patients with bone metastases, but other PET/CT values could be even more useful, according to research presented last week at the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium.
September 13, 2011
Prototype agent can find tumor cells
By AuntMinnie.com staff writers
A pilot study of five patients demonstrated that an antagonist agent, indium-111 (In-111) DOTA-BASS, outperformed the agonist Octreoscan, which is widely used to image neuroendocrine tumors with somatostatin receptors.
September 12, 2011
GE Hitachi may make Mo-99 in Ill.
By AuntMinnie.com staff writers
GE Hitachi Nuclear Energy will explore the feasibility of producing molybdenum-99 (Mo-99) at a nuclear power plant operated by Exelon in Clinton, IL.
September 12, 2011
Imaging shows efficacy of atherosclerosis drug
By Eric Barnes
In a study being touted as the first to use noninvasive imaging to test the efficacy of an atherosclerosis drug, researchers found that dalcetrapib reduced arterial inflammation and disease progression at PET/CT and MRI, respectively, according to results published September 12 in the Lancet.
September 12, 2011
2011 09 13 15 44 21 809 Dalcetrapib 450
GE launches healthcare tech venture
By AuntMinnie.com staff writers
GE Healthcare has launched Research Circle Technology, a new research-oriented subsidiary dedicated to developing metabolic imaging technology.
September 8, 2011
GE reaches nuclear cardiology milestone
By AuntMinnie.com staff writers
GE Healthcare said that it has received commitments from more than 100 global customers for its Alcyone nuclear cardiology platform.
September 7, 2011
Carestream debuts preclinical unit at WMIC
By AuntMinnie.com staff writers
Carestream Health is launching a new multimodality optical and x-ray system for small-animal imaging, called In-Vivo Xtreme, at this week's World Molecular Imaging Congress (WMIC) in San Diego.
September 7, 2011
GE gets 100th Discovery NM/CT 670 sale
By AuntMinnie.com staff writers
GE Healthcare has received an order to install its 100th Discovery NM/CT 670 hybrid SPECT/CT system.
September 6, 2011
Philips research center in Ohio lands grants
By AuntMinnie.com staff writers
The Philips Healthcare Global Advanced Imaging Innovation Center has received $2.5 million in research grants from the Ohio Third Frontier Commission.
September 6, 2011
Previous Page
Page 222 of 440
Next Page